JPS5536428A - Immunosuppressive agent - Google Patents

Immunosuppressive agent

Info

Publication number
JPS5536428A
JPS5536428A JP10995878A JP10995878A JPS5536428A JP S5536428 A JPS5536428 A JP S5536428A JP 10995878 A JP10995878 A JP 10995878A JP 10995878 A JP10995878 A JP 10995878A JP S5536428 A JPS5536428 A JP S5536428A
Authority
JP
Japan
Prior art keywords
agent
compound
immunosuppressive agent
methoxyphenyl
glutamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10995878A
Other languages
Japanese (ja)
Inventor
Hiroaki Munakata
Toshiaki Tsutsui
Shigeru Sato
Kazuo Honda
Makio Kobayashi
Kazuo Azuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Priority to JP10995878A priority Critical patent/JPS5536428A/en
Publication of JPS5536428A publication Critical patent/JPS5536428A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: To provide a low toxic immunosuppressive agent useful as a rejection suppressing agent in the organ transplantation, skin grafting, etc., remedy for autoimmune disease and rheumatism, and an antiinflammatory agent, containing N-(p- or m-methoxyphenyl)-L-glutamine.
CONSTITUTION: An immunosuppressive agent containing N-(p- or m-methoxyphenyl)-L-glutamine of formula I or II as an effective component. It can be administered orally or parenterally, with or without mixing with a carrier. The composition of the agent depends upon the method of administration, etc. Dose: 1W100mg/kg daily for parenteral administration and 5W500mg/kg daily for oral administration. The compound I or II can be prepared by reacting a compound with p- or m-methoxyaniline, and then reacting the resulting compound IV or V with hydrazine bydrate.
COPYRIGHT: (C)1980,JPO&Japio
JP10995878A 1978-09-07 1978-09-07 Immunosuppressive agent Pending JPS5536428A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10995878A JPS5536428A (en) 1978-09-07 1978-09-07 Immunosuppressive agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10995878A JPS5536428A (en) 1978-09-07 1978-09-07 Immunosuppressive agent

Publications (1)

Publication Number Publication Date
JPS5536428A true JPS5536428A (en) 1980-03-14

Family

ID=14523439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10995878A Pending JPS5536428A (en) 1978-09-07 1978-09-07 Immunosuppressive agent

Country Status (1)

Country Link
JP (1) JPS5536428A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011126099A1 (en) * 2010-04-02 2011-10-13 味の素株式会社 Prophylactic agent or therapeutic agent for diabetes or obesity

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011126099A1 (en) * 2010-04-02 2011-10-13 味の素株式会社 Prophylactic agent or therapeutic agent for diabetes or obesity
US8877739B2 (en) 2010-04-02 2014-11-04 Ajinomoto Co., Inc. Prophylactic agent or therapeutic agent for diabetes or obesity

Similar Documents

Publication Publication Date Title
KR930003908A (en) Inflammation, ischemia-induced cell damage and muscle dystrophy
JPS5536428A (en) Immunosuppressive agent
JPS52108028A (en) Remedies for dysacousis
JPS57109721A (en) Carcinostatic agent
JPS5350316A (en) Drug composition for oral administration
JPS5242838A (en) Synthetic process for coenzyme q group compounds
JPS55122715A (en) Antidiabetic agent
JPS5536453A (en) Novel immunosuppressive agent
JPS5352622A (en) Composition for preparation of bordeaux mixture
JPS5233682A (en) Preparation of 1,3-bis(2'-tetrahydrofuryl)-5-flurouracil
JPS6434965A (en) Novel aconitine based compound and analgesic and antiphlogistic agent containing said compound as active ingredient
JPS5295674A (en) Preparation of 4#-substituted-2-methyl-2-piperidinopropiophenone and i ts salts
JPS54132239A (en) Anti-tumor agent
JPS5746915A (en) Antiallergic agent
JPS5569569A (en) Carcinostatic
JPS52151141A (en) Preparation of 4-hydroxysalicylic acid anilide
JPS5346950A (en) (54)1-acetylaminotricyclo(4,3,1,12,5)undecane and its preparation
JPS5690075A (en) Cholagogue
JPS5498339A (en) Carcinostatic agent
JPS53127832A (en) Antiphkogistics for oral administration containing thiaprostaglandins
JPS525782A (en) Preparation of 1-phthalazinone
JPS5422326A (en) 3-trimethylsilymethyl-3-butenoic acid and its preparation
JPS5359674A (en) 1-piperidinoalkane-1,1-diphosphonic acid derivatives and herbicidescontaining the same as active agent
JPS5265281A (en) Preparation of n4-dimethylamino methylene-arabinofuranosil cytosine
JPS559031A (en) Pyrrole-type agricultural and horticultural fungicide